Los puntos clave no están disponibles para este artículo en este momento.
Here we provide a review of available literature pertaining to these challenges in the 225Acradiopharmaceutical field and also provide insight into how performed and planned efforts at TRIUMF - Canada's particle accelerator centre - aim to address these issues.
Robertson et al. (Wed,) studied this question.